Study S001416

Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05467514
Study type: INTERVENTIONAL
Phase: PHASE3
Masking: NONE
Status: COMPLETED
Enrollment: 35
Start: 2022-07-01
Primary completion: 2023-02-28
Lead sponsor: David Sanchez Garcia
Conditions: Diabetes Mellitus, Type 1
Interventions: DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

To assess the effect of liraglutide on carotid intima media thickness in patients with type 1 diabetes mellitus. [Baseline and 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.